Abstract. Dopamine amides of long chain fatty acids (NADA) 
Introduction
N-acyl dopamines (NADA) are biogenic conjugates of dopamine with long chain fatty acids.
Their endogenous nature was first proposed independently by Bezuglov et al. (1) and
Pokorski and Matysiak (2) . Subsequently, NADA with arachidonic, docosahexaenoic, oleic, palmitic and stearic acid residues were found in the nervous system of Rattus norvegicus and Bos taurus (0.1-6 pmol/g wet weight) (3, 4) , in two species of the Hydra genus (5) and in human plasma (6) . The targets of NADA are vanilloid receptor TRPV1 and cannabinoid receptor CB1, as well as several other proteins (7) .
Previously, others and we showed the ability of NADA to induce cell death in various cancer cell lines with a half-lethal concentration in range 2-50 µM (8) (9) (10) . This activity depends on the structure of the fatty acid residue and on the modification of dopamine moiety (9) and thus is specific. However, the exact molecular target of NADA leading to cell death induction is still unknown.
The aim of this study was to identify the cell death mode and the NADA receptor target in rat pheochromocytoma PC12 cell line. Receptor blockers SR141716A (CB1), SR144528 (CB2), capsazepine (TRPV1), haloperidol (D2, D3), T0070907 (PPAR-gamma) and autophagy inhibitor hydroxychloroquine sulphate were from Sigma-Aldrich, USA; O-1918 (non-CB1-non-CB2) was from Cayman Europe, Estonia; pancaspase inhibitor Z-VAD-FMK and caspase fluorogenic substrates Ac-LEHD-AFC and Ac-DEVD-AFC were from Tocris Bioscience, UK.
Materials and Methods

Rat
PC12 cells were maintained at 37°C under 5% CO 2 in the RPMI 1640 medium, supplemented with 2 mM L-glutamine, 7.5% fetal bovine serum, 100 U/ml penicillin, 0.1 mg/ml streptomycin and 0.25 µg/ml amphotericin B. Cells were passaged each 3 days and continiously grown for no more than 40 passages. Attached cells were detached with 0.25% trypsin in 0.53 mM EDTA in Hanks' salts. Cells were counted using a glass hemocytometer. were without DMSO (no difference with the control 0.5% DMSO was found, data not shown).
The effect of test substances on the cell viability was evaluated using the MTT test (based on the MTT dye reduction by mitochondria of living cells) (11) .
For the MTT test, after removal of the medium with the test compounds, the cells and the controls were incubated for 1.5 h with 0.5 mg/ml of MTT in Hank's solution, supplemented with 10 mM of D-glucose. After this incubation, the solution was removed and the cells were dissolved in DMSO. The amount of the reduced dye was determined colorimetrically at 594 nm with a reference wavelength 620 nm using an EFOS 9505 photometer (Sapphire, Moscow, Russia). Additionally, the attachment and cell shape of adherent cells were evaluated microscopically.
To perform a pharmacological downregulation of the surface receptor sensitive to O-1819 and on-CB1-non-CB2 agonists, the cells were incubated with these substances for 3 days. At the end of the incubation, the cells were washed with the fresh medium and NADA solution was added as described before for 1 h, after which it was replaced with a fresh cultivation medium for 24 h. Assessment of the cell viability was carried out using the MTT assay.
The determination of caspase activity was performed using the specific substrates labeled with a fluorescent label AFC. The experiment was performed in 6-well plates. After the 24 hour incubation, the medium was discarded and 1 ml of the lysis buffer (20 mM HEPES, 10 mM KCl, 1.5 M MgCl 2 , 0.5% NP-40, 1 mM dithiothreitol, 1 mg/ml pepstatin A, 1 mg/ml aprotinin, 5 mg/ml leupeptin, 1 mM PMSF) was added to the wells and left for 10 To check the apoptosis-specific DNA fragmentation, DNA was extracted using the Biotechrabbit Blood DNA kit according to the manufacturer's instructions and analyzed using agarose gel electrophoresis (gel percentage 2.0, constant voltage 137 V, Tris-Borate-EDTA buffer).
Each experiment was repeated three times. Curves for calculating the 50% lethal dose (LD 50 ) were generated using the GraphPad Prism software (www.graphpad.com). Data are presented as mean ± standard deviation. Data were compared using the unpaired Student's t test; p values of 0.05 or less were considered significant.
Results
In our previous work, we found dopamine amides of arachidonic (AA-DA), docosahexaenoic (DHA-DA) and oleic (Ol-DA) acids to be cytotoxic for PC12 cells with LC 50 =2-4 µM (10). In this work, we focused on the evaluation of the cell death type, induced by these substances in PC12 cells, and on the identification of the surface receptor engaged in this process.
The minimum time of NADA exposition, enough for cell death induction was shown to be 1 h; even if the substance was washed out, the cell death program unrolled from this time point (data not illustrated). The pre-treatment with an autophagy inhibitor hydroxychloroquine (12) did not alter cell survival, while the pan-caspase inhibitor Z-VAD-FMK was able to prevent NADA cytotoxicity ( Figure 1 ). From this we suggested that NADA induce apoptosis, and confirmed it using three additional methods: fluorometric caspase activation assay (Figure 2A ), ApoTRACE apoptosis detection kit ( Figure 2B ), and DNA laddering assay ( Figure 2C ). We observed activation of both caspase 3 and 9, and, together with our previous data on the ability of NADA to induce ROS accumulation (10), we concluded that these substances induce apoptosis via the intrinsic pathway.
To identify the receptor responsible for NADA cell death induction, we pre-incubated the cells with a panel of blockers of putative and known endocannabinoid and endovanilloid receptors ( Figure 1 ). The only active substance was O-1918, a non-CB1-non-CB2 receptor blocker (13) . To further confirm the participation of an O-1918-sensitive receptor in NADA cytotoxicity, we performed a pre-incubation with the inhibitor for 72 h, as this technique is known to diminish surface receptor density (14) . Then the inhibitor was washed out, and the cells were incubated with NADA for 1 h with washing out of the substances at the end. We found that such pretreatment led to a significant decrease of NADA cytotoxicity (Figure 3) , which indicates the change of the receptor density or sensitivity.
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The non-CB1-non-CB2 receptor group comprises a number of proteins, which include
as-yet-unidentified/putative receptor(s), and established orphan GPCRs, namely GPR92, GPR55, and GPR119 (15) . To further evaluate the participation of these receptors in the NADA cell death induction, we used four known ligands of the receptors of this group, namely the GPR55 ligand N-palmitoyl ethanolamide (Palm-EA (16)), the GPR55 (16) and GPR119 (17) ligand N-oleoyl ethanoleamide (Ol-EA), the GPR92 ligand N-arachidonoyl glycine (AA-Gly (18)), and the putative endothelial cannabinoid receptor ligand Narachidonoyl serine (AA-Ser (19)). First, we checked the ability of these substances to mimic NADA action on PC12 cells and found that they indeed induced cell death, which was blocked by O-1918 ( Figure 4 ). Next we incubated the cells with a non-lethal concentration of each of these substances for 72 h to induce the appropriate receptor downregulation and tested the activity of NADA on the survived cells. Palm-EA and Ol-EA pretreatment was able to almost completely prevent the NADA cytotoxicity, while AA-Gly and AA-Ser were without effect ( Figure 5 ).
Discussion
The main result of this research is the demonstration for the first time that NADA induce apoptosis of a cancer cell line via the activation of the nonclassical cannabinoid non-CB1-non-CB2 receptor. The cytotoxic properties of NADA and their analogs was described in literature many times (8-10), with some insights for the intracellular ROS-and NOdependent mechanism of their action (10). However, our study is the first one to identify the cell surface molecular target of these effects. We checked a set of major cellular receptor inhibitors that blocked activity of surface classical cannabinoid (CB1, CB2), dopamine (D2, D3), vanilloid (TRPV1), non-CB1-non-CB2 receptors, as well as an inhibitor of nuclear receptor PPARγ, known to be involed in pro-apoptotic action of capsaicin -structural analog NADA; all other inhibitors were ineffective (Fig. 1) . O-1918, which lacks detectable affinity for CB1 and CB2 receptors, is a structural analog of abnormal cannabidiol and was reported to be a neutral antagonist of the putative endothelial non-cannabinoid receptor (21, 22) . The critical involvement of the non-CB1-non-CB2 receptor in the cytotoxic effect of NADA is supported by the results of pharmacological blocade of the aforementioned receptor using a prolonged incubation with O-1918, Palm-EA and Ol-EA, which dramatically increased viability of the PC12 cells upon NADA treatment (Fig. 3, 5) . Activation of this putative receptor with three tested NADA (Ol-DA, AA-DA or DHA-DA) leads to the promotion of apoptotic death of PC12 cells, which was confirmed by three independent tests: caspase activation, DNA laddering and ApoTRACE assays. We can speculate that the downstream mechanism of NADA-induced apoptosis initiated by interaction with putative non-CB1-non-CB2 receptor is linked to the reactive oxygen species overproduction, as was recently demonstrated by us (10).
O-1918 can block several non-cannabinoid receptors (glial, GPR55, GPR18) (22) . The NADA cytotoxicity change after the non-CB1-non-CB2 agonists pretreatment could possibly narrow this list to GPR55, which is in line with the presence of the functional GPR55 in the PC12 cells (23) and with the ability of the endocannabinoid anandamide to induce cholangiocarcinoma cell death via the GPR55 activation (24) . Another indirect evidence for the GPR55 participation is that this receptor is able to switch its signal transduction pathways depending on the ligand (25) , and that anandamide activation of this receptor induced cell death (24) , while the activation by lysophosphatidylinositol did not (23) . However, the differentiation of the observed NADA effects between all these receptors, as well as further elucidation of the intracellular transduction pathways during the NADA-induced apoptosis of cancer cells were not the subject of this paper and will be reported elsewhere. 
